Klinische Studie

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve System (FASTR-II) (IDE-G210258)

NCT: NCT06898515 · RECRUITING

NCT-IDNCT06898515

Medizinische Daten: StatusRECRUITING

Startdatum2025-07-14

SponsorReprieve Cardiovascular, Inc (INDUSTRY)

First posted2025-03-27

Last updated2026-10-08

Kurzzusammenfassung

The objective of this study is to prospectively compare decongestive therapy administered by the Reprieve System to Optimal Diuretic Therapy (ODT) in the treatment of patients diagnosed with acute decompensated heart failure (ADHF). The main objective is to determine if the Reprieve System can more efficiently decongest ADHF patients in comparison to Control Therapy.

Offizielle Quelle

Auf ClinicalTrials.gov ansehen →

Daten aus der ClinicalTrials.gov-API. Den aktuellsten Status finden Sie im offiziellen Eintrag.